Carr Zyad J, Yan Luying, Chavez-Duarte Jose, Zafar Jill, Oprea Adriana
Yale University School of Medicine, New Haven, CT, 06520, USA.
Department of Anesthesiology, Yale New Haven Hospital, New Haven, CT, 06510, USA.
Int J Gen Med. 2022 Feb 23;15:2087-2100. doi: 10.2147/IJGM.S266217. eCollection 2022.
The idiopathic interstitial pneumonias (IIP) constitute a large cohort of the over 200 subtypes of interstitial lung disease (ILD). Idiopathic pulmonary fibrosis (IPF) is the most widely studied, arguably the most severe etiology of ILD and the most common IIP diagnosis. The objective of this narrative review is to outline the current evidence on optimal perioperative management of IPF. PubMed, Embase and Web of Science were analyzed for appropriate peer-reviewed references by utilizing key word search ("interstitial lung disease" OR "idiopathic pulmonary fibrosis" OR "idiopathic interstitial pneumonitis" OR "ILD" OR "IPF" AND "surgery" OR "anesthesia" OR "perioperative") within the past thirty years (1990-current). Non-English language references were excluded. A total of 205 references were curated by the authors. Eighty-seven consensus statements, clinical trials, retrospective cohort studies or case series met criteria and were incorporated into the findings of this narrative review.
After review, we conclude that complications, dominated by postoperative pulmonary complications, pose a significant barrier to safe perioperative care of patients with IPF. Ensuring that the preoperative IPF patient has been medically optimized is important for minimizing this risk. Initial assessment of the ARISCAT score, pulmonary function studies and cardiopulmonary exercise testing may identify IPF patients at particularly high perioperative pulmonary risk. Identifying IPF patients with 6-12-month declines in D of >15%, V <8.3 mL/kg/min, <80% predicted value FVC, a 50-meter reduction in the 6MWT or preoperative home oxygen use may be helpful in preoperative risk stratification. Medically optimizing treatable co-morbidities should be a priority in preoperative assessment. Regional or neuraxial anesthesia should be considered an optimal technique for the avoidance of general anesthesia related complications when indicated. Acute exacerbation and postoperative pneumonia have been identified as important postsurgical complications in both thoracic and nonthoracic surgical populations.
特发性间质性肺炎(IIP)是间质性肺疾病(ILD)200多种亚型中的一大类。特发性肺纤维化(IPF)是研究最为广泛的ILD病因,可说是最严重的病因,也是IIP最常见的诊断类型。本叙述性综述的目的是概述IPF围手术期最佳管理的当前证据。通过在过去三十年(1990年至今)内利用关键词搜索(“间质性肺疾病”或“特发性肺纤维化”或“特发性间质性肺炎”或“ILD”或“IPF”以及“手术”或“麻醉”或“围手术期”)对PubMed、Embase和科学网进行分析,以查找合适的经同行评审的参考文献。排除非英语语言参考文献。作者共整理了205篇参考文献。87条共识声明、临床试验、回顾性队列研究或病例系列符合标准,并纳入本叙述性综述的研究结果。
经审查,我们得出结论,以术后肺部并发症为主的并发症对IPF患者的安全围手术期护理构成重大障碍。确保术前IPF患者的病情在医学上得到优化对于将此风险降至最低很重要。ARISCAT评分的初始评估、肺功能研究和心肺运动测试可能会识别出围手术期肺部风险特别高的IPF患者。识别出在6至12个月内D下降>15%、V<8.3 mL/kg/min、FVC预测值<80%、6分钟步行试验(6MWT)减少50米或术前在家使用氧气的IPF患者可能有助于术前风险分层。在术前评估中,优先对可治疗的合并症进行医学优化。当有指征时,区域或神经轴麻醉应被视为避免全身麻醉相关并发症的最佳技术。急性加重和术后肺炎已被确定为胸科和非胸科手术人群中重要的术后并发症。